Overcoming Tumor Resistance: Targeting Stromal Components in Cancer Treatment
DOI:
https://doi.org/10.47611/jsrhs.v13i4.8246Keywords:
Cancer, Diagnosis, Tumor, Clinical Trials, Chemotherapy, Radiation Therapy, Immunotherapy, AIAbstract
The word “cancer” is still frightening to hear, despite the great improvement in cancer treatments and outcomes in recent years. Causing more than 10 million deaths annually, cancer stands as the second leading cause of death globally. Cancer is a generic term for many diseases that may impact any body part. While global oncology treatment strategies have improved, there has been a rise in cancer cases as a whole. Currently, most antitumor therapies target and eliminate cancer cells, and are not designed to affect the tumor stroma directly. Tumor recurrence can result from the interactions of the tumor stroma with both cancer cells and anticancer therapies. This research paper explores the relationship between cancer cells and the tumor stroma by evaluating the effectiveness of current cancer therapies alongside stromal-targeted treatments. The stroma promotes tumor growth through its interactions with the cancer cells, leading to resistance from traditional therapies. The tumor stroma can lead to reduced effectiveness of cancer therapy strategies through its various components. Therefore, proposed solutions should not only target cancer cells but aim to disrupt the stroma’s support or develop it into a tumor-repressive state. Addressing both cancer cells and the stromal environment may improve treatment effectiveness and reduce the likelihood of tumor relapse.
Downloads
References or Bibliography
Anderson, N. M., & Simon, M. C. (2020). The tumor microenvironment. Current Biology, 30(16), R921–R925.
https://doi.org/10.1016/j.cub.2020.06.081
Cancer Facts & Figures 2023. (n.d.). American Cancer Society.
ml
Chemotherapy to treat cancer. (2022, August 23). Cancer.gov.
https://www.cancer.gov/about-cancer/treatment/types/chemotherapy
Chen Z, Xu L, Shi W, Zeng F, Zhuo R, Hao X, et al.. Trends of female and male breast cancer incidence at the
global, regional, and national levels, 1990–2017. Breast Cancer Res Treat (2020) 180(2):481–90. [PubMed]
[Google Scholar]
ClinicalTrials.gov. (n.d.). https://clinicaltrials.gov/search?cond=cancer&term=CD40
ClinicalTrials.gov. (n.d.-b).
https://clinicaltrials.gov/study/NCT04491084?cond=cancer%20CD40&aggFilters=results:with&rank=2
ClinicalTrials.gov. (n.d.-c).
https://clinicaltrials.gov/study/NCT04337931?cond=cancer%20CD40&aggFilters=results:with&rank=3&p
age=1&limit=10
ClinicalTrials.gov. (n.d.-d).
https://clinicaltrials.gov/study/NCT04491084.
ClinicalTrials.gov. (n.d.-e). https://clinicaltrials.gov/study/NCT04337931.
ClinicalTrials.gov. (n.d.-f). https://clinicaltrials.gov/study/NCT04059588.
ClinicalTrials.gov. (n.d.-g). https://clinicaltrials.gov/study/NCT02225002.
ClinicalTrials.gov. (n.d.-h). https://clinicaltrials.gov/study/NCT06205849.
Hyperthermia to treat cancer. (2021). Cancer.gov.
https://www.cancer.gov/about-cancer/treatment/types/hyperthermia
Miller, K. D., Nogueira, L., Devasia, T., Mariotto, A. B., Yabroff, K. R., Jemal, A., Kramer, J., & Siegel, R. L.
(2022). Cancer treatment and survivorship statistics, 2022. CA a Cancer Journal for Clinicians, 72(5),
–436. https://doi.org/10.3322/caac.21731
National Cancer Institute. (2023). Chemotherapy to treat cancer. National Institutes of Health. https://www.cancer.gov/about-cancer/treatment/types/chemotherapy
National Cancer Institute. (2019). Hyperthermia to treat cancer. National Institutes of Health. https://www.cancer.gov/about-cancer/treatment/types/hyperthermia
National Cancer Institute. (2019). Immunotherapy to treat cancer. National Institutes of Health. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy
National Cancer Institute. (2021). Radiation therapy to treat cancer. National Institutes of Health. https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy
National Cancer Institute. (2015). Surgery to treat cancer. National Institutes of Health. https://www.cancer.gov/about-cancer/treatment/types/surgery
Research areas - Global health. (2022). Cancer.gov.
https://www.cancer.gov/research/areas/global-health
Radiation therapy for cancer. (2019). Cancer.gov.
https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy
Su, M., Nethi, S. K., Dhanyamraju, P. K., & Prabha, S. (2023). Nanomedicine Strategies for Targeting Tumor
stroma. Cancers, 15(16), 4145. https://doi.org/10.3390/cancers15164145
Texas cancer diagnoses expected to hit record high (2024). axios.com.
https://www.axios.com/local/houston/2024/01/18/new-cancer-diagnoses-record-high-texas
Treatment for cancer. (n.d.). Cancer.gov. https://www.cancer.gov/about-cancer/treatment
Tune, Bernadette & Sim, Maw Shin (Gareth) & Poh, Chit & Guad, Rhanye & Woon, Choy & Hazarika, Iswar &
Das, Anju & Rajan, Mariappan & Sekar, Mahendran & Subramaniyan, Vetriselvan & Fuloria, Neeraj &
Fuloria, Shivkanya & Batumalaie, Kalaivani & Wu, Yuan-Seng. (2022). Matrix Metalloproteinases in
Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors. Journal of Oncology.
1-25. 10.1155/2022/3249766
Valkenburg, Kenneth C, et al. “Targeting the Tumour Stroma to Improve Cancer Therapy.” Nature Reviews. Clinical
Oncology, U.S. National Library of Medicine, June 2018,
www.ncbi.nlm.nih.gov/pmc/articles/PMC5960434/.
Xiaomei Ma ,Herbert Yu (2007).Global Burden of Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994799/
Published
How to Cite
Issue
Section
Copyright (c) 2024 Tanvi Kadiri; Dr. Prahlad Parajuli, Prof. Virgel Torremocha, Jothsna Kethar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
